Satisfaction with almost every major aspect of the U.S. health care system has dropped since 2010, a Gallup poll released this week found. The Biden administration has announced several initiatives to address both the quality and cost of care.

"For too long, corporate special interests and trickle-down economics have allowed big pharma to make record profits, while millions of Americans struggle to afford health care and prescription drugs to treat common and chronic conditions," the White House said in a fact sheet. "As part of the President's Bidenomics agenda, the Biden-Harris administration is cracking down on price gouging and taking on special interests to lower costs for consumers and ensure every American has access to high-quality, affordable health care."

The broad-based actions that were announced include plans to reduce prescription drug costs; scrutinize anticompetitive acquisitions and practices; and build on past actions to increase health-care competition and lower prescription drug costs.